Karen Joy Shaw

8.3k total citations · 1 hit paper
117 papers, 6.5k citations indexed

About

Karen Joy Shaw is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Karen Joy Shaw has authored 117 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 53 papers in Molecular Biology and 31 papers in Molecular Medicine. Recurrent topics in Karen Joy Shaw's work include Antifungal resistance and susceptibility (33 papers), Antibiotic Resistance in Bacteria (31 papers) and Bacterial Genetics and Biotechnology (26 papers). Karen Joy Shaw is often cited by papers focused on Antifungal resistance and susceptibility (33 papers), Antibiotic Resistance in Bacteria (31 papers) and Bacterial Genetics and Biotechnology (26 papers). Karen Joy Shaw collaborates with scholars based in United States, United Kingdom and Russia. Karen Joy Shaw's co-authors include R S Hare, George H. Miller, Philip N. Rather, Jeffrey B. Locke, M.T. Hilgers, Ashraf S. Ibrahim, Michael R. Barbachyn, Claire M. Berg, Beth DiDomenico and Paul A. Mann and has published in prestigious journals such as Nucleic Acids Research, Molecular Cell and Molecular and Cellular Biology.

In The Last Decade

Karen Joy Shaw

117 papers receiving 6.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes

1993 853 citations Karen Joy Shaw, Philip N. Rather et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Joy Shaw United States	46	2.7k	2.5k	2.1k	1.4k	1.0k	117	6.5k
Naoki Kato Japan	40	2.4k 0.9×	1.2k 0.5×	2.0k 1.0×	906 0.7×	489 0.5×	150	6.0k
R S Hare United States	35	1.4k 0.5×	2.7k 1.1×	1.8k 0.9×	2.3k 1.7×	612 0.6×	75	5.6k
Paul M. Dunman United States	50	5.6k 2.1×	4.7k 1.9×	1.3k 0.6×	692 0.5×	1.6k 1.6×	127	8.7k
Alexander S. Mankin United States	56	6.9k 2.5×	1.6k 0.6×	1.2k 0.6×	825 0.6×	2.1k 2.0×	151	9.1k
Richard Bonnet France	48	4.1k 1.5×	1.3k 0.5×	4.5k 2.2×	1.4k 1.0×	1.0k 1.0×	170	8.9k
Timothy Palzkill United States	49	3.1k 1.1×	1.0k 0.4×	2.9k 1.4×	825 0.6×	1.3k 1.2×	180	6.8k
Michel Arthur France	61	4.8k 1.8×	5.0k 2.0×	2.7k 1.3×	2.5k 1.8×	2.5k 2.5×	193	11.0k
Sergei B. Vakulenko United States	38	1.8k 0.7×	1000 0.4×	2.3k 1.1×	494 0.4×	500 0.5×	101	4.2k
Steven J. Projan United States	55	6.7k 2.4×	5.5k 2.2×	2.2k 1.1×	752 0.5×	2.5k 2.5×	98	10.4k
Ronald A. Skurray Australia	53	5.5k 2.0×	3.6k 1.4×	3.7k 1.8×	728 0.5×	3.3k 3.2×	134	10.6k

Countries citing papers authored by Karen Joy Shaw

Since Specialization

Citations

This map shows the geographic impact of Karen Joy Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Joy Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Joy Shaw more than expected).

Fields of papers citing papers by Karen Joy Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Joy Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Joy Shaw. The network helps show where Karen Joy Shaw may publish in the future.

Co-authorship network of co-authors of Karen Joy Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Joy Shaw. A scholar is included among the top collaborators of Karen Joy Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Joy Shaw. Karen Joy Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giamberardino, Charles, Wiley A. Schell, Jennifer L. Tenor, et al.. (2022). Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis. mBio. 13(6). e0234722–e0234722. 8 indexed citations

Shaw, Karen Joy, Nicola Singleton, Tricia M. McKeever, et al.. (2021). A low exhaled nitric oxide level excludes a short‐term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo‐controlled trial. Respirology. 26(7). 666–672. 6 indexed citations

Zhu, YanChun, et al.. (2020). In Vitro Activity of Manogepix against Multidrug-Resistant and Panresistant Candida auris from the New York Outbreak. Antimicrobial Agents and Chemotherapy. 64(11). 33 indexed citations

Trzoss, Michael, Jonathan A. Covel, Mili Kapoor, et al.. (2019). Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp. Bioorganic & Medicinal Chemistry Letters. 29(23). 126713–126713. 18 indexed citations

Locke, Jeffrey B., Gary E. Zurenko, Karen Joy Shaw, & Kenneth F. Bartizal. (2013). Tedizolid for the Management of Human Infections: In Vitro Characteristics. Clinical Infectious Diseases. 58(suppl_1). S35–S42. 86 indexed citations

Locke, Jeffrey B., et al.. (2011). Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05. Antimicrobial Agents and Chemotherapy. 56(1). 332–340. 59 indexed citations

Shaw, Karen Joy, Susan M. Poppe, Ronda D. Schaadt, et al.. (2008). In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains. Antimicrobial Agents and Chemotherapy. 52(12). 4442–4447. 153 indexed citations

Kedar, G. C., Vickie Brown‐Driver, M.T. Hilgers, et al.. (2007). Evaluation of the metS and murB Loci for Antibiotic Discovery Using Targeted Antisense RNA Expression Analysis in Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 51(5). 1708–1718. 13 indexed citations

Wiener, John J. M., Laurent Gomez, Hariharan Venkatesan, et al.. (2007). Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains. Bioorganic & Medicinal Chemistry Letters. 17(10). 2718–2722. 50 indexed citations

10.

Shaw, Karen Joy. (2003). Transcriptional profiling and drug discovery. Current Opinion in Pharmacology. 3(5). 508–512. 20 indexed citations

11.

Shaw, Karen Joy. (2002). Pathogen genomics: impact on human health.. Humana Press eBooks. 6 indexed citations

12.

Shaw, Karen Joy, et al.. (2002). Pathogen Genomics. Humana Press eBooks. 1 indexed citations

13.

Miller, George H., et al.. (1997). Cloning and characterization of an aminoglycoside 6'-N-acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile. Antimicrobial Agents and Chemotherapy. 41(11). 2439–2447. 14 indexed citations

14.

Zhi, Hong, et al.. (1994). Cloning and Characterization of KNR4 , a Yeast Gene Involved in (1,3)-β-Glucan Synthesis. Molecular and Cellular Biology. 14(2). 1017–1025. 26 indexed citations

15.

Rather, Philip N., Erzsébet Orosz, Karen Joy Shaw, R S Hare, & George H. Miller. (1993). Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii. Journal of Bacteriology. 175(20). 6492–6498. 62 indexed citations

16.

Dornbusch, K., George H. Miller, R S Hare, & Karen Joy Shaw. (1990). Resistance to aminoglycoside antibiotics in Gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. Journal of Antimicrobial Chemotherapy. 26(1). 131–144. 55 indexed citations

17.

Shaw, Karen Joy, Claudia Cramer, Ronald Mierzwa, et al.. (1989). Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 33(12). 2052–2062. 50 indexed citations

18.

Shaw, Karen Joy, W Montague, & D.J. Pallot. (1989). Biochemical studies on the release of catecholamines from the rat carotid body in vitro. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1013(1). 42–46. 36 indexed citations

19.

Shaw, Karen Joy, et al.. (1988). Regulated Secretion of MuGM-CSF in Saccharomyces cerevisiae via GAL1:MFα1 Prepro Sequences. DNA. 7(2). 117–126. 8 indexed citations

20.

Shaw, Karen Joy & Claire M. Berg. (1979). ESCHERICHIA COLI K-12 AUXOTROPHS INDUCED BY INSERTION OF THE TRANSPOSABLE ELEMENT Tn5. Genetics. 92(3). 741–747. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact